Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 9, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 February 2026 - 11:55

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 9, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/uplizna

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters